Author name: admin

We are delighted and honoured to have a symposium dedicated to the EuCARE project during ICAR 2024. The Italian Conference on Aids and Antiviral Research taking place in Rome from 19 to 21 June 2024. SARS-COV-2 and its continuous evolution still pose scientific questions and challenges, including those related to long-COVID. This pandemic highlighted the […]

EuCARE partners from ASST Santi Paolo were present at the 34th European Congress of Clinical Microbiology and Infectious Diseases 2024 in Barcelona Spain. Dr. Andrea Santoro from the ASST Santi Paolo e Carlo presented a poster entitled “Reduction of post COVID-19 condition during the Omicron wave: results from the EuCARE POSTCOVID Study” and was awarded

The 5thEdition of the European Mental Health awareness week took place between 13th and 19th of May 2024.This week is a pan-European initiative and is run by the non governmental organization (NGO) Mental Health Europe, the largest independent European mental health NGO. This week is important for bringing awareness about the importance of mental health

For the third consecutive year, the prestigious AREVIR meeting in Cologne, Germany, welcomed a dedicated session by EuCARE, marking yet another milestone in our collaborative efforts to combat infectious diseases. The session was brimming with lively exchanges of knowledge and innovative ideas, showcasing the remarkable progress achieved by the project across various fronts. Led by

We’re thrilled to share that EuCARE will be featured in a special session at the AREVIR Meeting 2024 for the third time! 🎉 Our team has the opportunity to showcase our latest research findings and collaborations in the fight against infectious diseases. From groundbreaking studies to impactful initiatives, EuCARE is committed to making a difference

🌟 EuCARE Surpasses 50,000 Patient Milestone! The EuCARE initiative has reached a significant milestone, enrolling over 50,000 patients across its clinical cohorts. These cohorts include the Hospitalised cohort, focusing on patients with COVID-19, and the Post-COVID cohort (PASC), investigating long-term sequelae of the virus. Enrollment status for clinical studies 🔬 Unprecedented Progress in Research: EuCARE

EuCARE partners made contributions to the Conference on Retroviruses and Opportunistic Infections 2024 (CROI), held from March 3rd to 6th, 2024. This prestigious conference, established in 1993, serves as a vital platform for basic scientists and clinical investigators to exchange insights into the epidemiology and biology of human retroviruses and associated diseases. Pontus Hegberg, a

On January 30, the first meeting of the Coordination Board, a COMECT (Coordination Mechanism for Cohorts and Trials) activity, was held, gathering together the Cohort Coordination Board (CCB) and the Trial Coordination Board (TCB). Representatives of the existing network and infrastructure were present, including the TCB Tx Pillar and the Vaccine Pillar. Among the discussion

This cohort study within the EuCARE project entitled: “In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project”, uses data from 38,585 adult patients hospitalised with SARS-CoV-2 Wild-type, Alpha, Delta, or Omicron infection across 10 centres in 9 countries: Germany, Italy, Kenya, Lithuania, Mexico, Poland, Portugal,

On the past 21st of December 2023, Miłosz Parczewski, EuCARE partner from the Pomeranian Medical University in Poland, was appointed National Consultant for Infectious Diseases by Polish Minister of Health. This achievement is an important recognition of Milosz important clinical and research work on Infectious Diseases and specially in Virology. Miłosz Parczewski received the MD